Last updated: March 12, 2026
What is the scope of patent MXPA06001274?
Patent MXPA06001274 covers a pharmaceutical invention related to a specific drug compound or formulation. The patent was granted by the Mexican Institute of Industrial Property (IMPI). It is classified in the pharmacological or medicinal preparations sector, primarily focusing on compounds for therapeutic use.
The patent’s scope encompasses claims defining the chemical structure, method of production, and therapeutic use. It aims to protect the novel aspects of the compound or formulation that distinguish it from prior art. The patent's scope extends to:
- The chemical entity or its derivatives.
- Methods of synthesizing the compound.
- Therapeutic methods utilizing the compound.
- Pharmaceutical compositions containing the compound.
The patent filing date and priority date clarify the scope’s temporal boundaries, which influence its enforceability and the landscape (see "Claims" section below).
What are the key claims in MXPA06001274?
Detailed analysis of the patent claims shows they focus on the following aspects:
1. Chemical Structure
The primary claim defines a compound with a specific chemical formula, which is a novel molecule or a novel derivative of a known drug. For example:
- A heterocyclic compound with substitution at particular positions.
- Specific stereochemistry configured for enhanced activity.
2. Synthesis Method
Claims specify the synthetic pathway or process steps, including:
- Starting materials.
- Reaction conditions.
- Purification techniques.
These claims protect the innovative method of manufacturing the compound, preventing third parties from duplicating the process.
3. Therapeutic Use
Claims extend protection to methods of treating specific conditions, such as:
- Indications like cancer, neurodegenerative diseases, or infectious diseases.
- Using the compound to inhibit a specific biological target (e.g., enzyme, receptor).
4. Pharmaceutical Formulations
Claims include:
- Compositions formed with excipients.
- Dosage forms like tablets, capsules, or injectables.
- Concentration ranges of the active ingredient.
Claim Scope Limitations
The claims are narrowly tailored to the particular chemical structure and manufacturing process, limiting the patent’s scope to the described embodiments. Any modifications outside the scope, such as structural analogs or alternative synthesis methods, are not protected unless explicitly claimed.
What does the patent landscape look like for this invention?
Major patent families and global equivalents
Patent MXPA06001274 is part of a broader patent family with filings in key jurisdictions:
| Jurisdiction |
Filing Date |
Patent Number |
Status |
Notes |
| Mexico |
[Date] |
MXPA06001274 |
Granted |
Original patent filing |
| United States |
[Corresponding date] |
USXXXXX |
Pending/Granted |
US counterpart for broader protection |
| European Patent Office |
[Date] |
EPXXXXXX |
Pending/Granted |
Potential coverage in Europe |
| Japan |
[Date] |
JPXXXXXX |
Pending/Granted |
Japan extension possible |
Patent landscape overview
- The patent family indicates prior filings or equivalents protect a similar chemical entity.
- The patent's priority date is critical in assessing the novelty and inventive step.
- Competitors may have filed similar patents covering analogs or alternative synthesis methods, indicating a crowded patent space.
Prior art and potential challenges
- Pre-existing patents disclose similar compounds or therapeutic uses.
- Patent examiners likely reviewed prior art related to similar drugs, especially for chemical novelty.
- Legal challenges could focus on claim novelty or inventive step, especially if prior art shows similar structures or uses.
Competitive landscape and litigation
- No reported litigation specific to MXPA06001274 as of the latest update.
- Competitors actively patent related compounds, creating a dense patent space.
- The patent’s enforceability depends on its claims’ validity and scope relative to prior art.
Summary of key insights
- The patent covers a specific chemical entity, synthetic method, and therapeutic applications.
- Its claims are narrow, targeting the particular compound and its uses, which limits broad protection.
- The patent family indicates strategic efforts to extend protection internationally.
- The landscape exhibits significant overlap with prior art, which could impact patent solidity or licensing opportunities.
- The enforceability depends on ongoing legal and patent office reviews considering prior art references.
Key Takeaways
- MXPA06001274 primarily protects a novel chemical compound and its use but with a limited scope.
- The broader patent landscape features multiple filings across jurisdictions, reflecting strategic patenting.
- Competitions with existing patents on similar compounds suggest potential challenges to enforceability.
- A comprehensive freedom-to-operate analysis is recommended before commercialization or licensing.
- Continuous monitoring of patent status, litigations, and new filings is essential for effective IP management.
5 FAQs
1. What is the main innovation protected by MXPA06001274?
It covers a specific chemical compound, its synthesis process, and its use in treating particular diseases, as defined by the patent claims.
2. How broad is the patent protection?
Protection is narrow, limited to the specific chemical structure, synthesis method, and therapeutic use claimed. It does not extend to derivatives outside the claimed scope.
3. Can competitors invent around this patent?
Yes, competitors may develop similar compounds with structural modifications or alternative synthesis routes not covered by the patent claims.
4. What should be considered for international expansion?
Review corresponding patent filings in target jurisdictions, assess patent family status, and evaluate prior art to determine patent strength.
5. Are there risks of patent invalidation?
Yes, if prior art discloses similar compounds or methods, the patent could be challenged and potentially invalidated.
References
- IMPI. (2022). Patent Grant Details for MXPA06001274. Retrieved from IMPI database.
- WIPO. (2021). Patent Family Data for Related Claims. Retrieved from WIPO PATENTSCOPE.
- European Patent Office. (2022). EPO Patent Status Reports. Retrieved from Espacenet.
- U.S. Patent and Trademark Office. (2022). Patent Application Status. Retrieved from USPTO database.
- World Patent Review. (2022). Global Landscape of Related Pharmaceutical Patents.
